Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Amyloid: The Journal of Protein Folding Disorders Année : 2013

Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis.

Résumé

BACKGROUND: Familial amyloid polyneuropathy (FAP) mainly targets the peripheral nervous system and heart. Early noninvasive detection of cardiac impairment is critical for therapeutic management. AIM: To assess if amino-terminal pro-brain natriuretic peptide (NT-proBNP) or troponin T (cTnT) can predict echocardiographic left-ventricle (LV) impairment in FAP. METHODS: Thirty-six asymptomatic carriers and patients with FAP had echocardiographic measurement of left-ventricular (LV) systolic function, hypertrophy (LVH) and estimation of filling pressure (FP). RESULTS: Overall, median age, NT-proBNP, and LV ejection fraction were, respectively, 59 years (41-74), 323 pg/ml (58-1960), and 60% (51-66). Twelve patients had increased cTnT. Prevalence of ATTR gene mutations was 53% for Val30Met. Four individuals were asymptomatic, 6 patients had isolated neurological clinical signs, and 26 had echo-LV abnormalities. The ROC curve identified NT-proBNP patients with echo-LV abnormalities (area: 0.92; (0.83-0.99), p = 0.001) at a threshold >82 pg/ml with a sensitivity of 92%, and a specificity of 90%. Increased in NT-proBNP occurred in patients with SD and/or LVH with or without increase in FP. Elevated cTnT (>0.01 ng/ml) was only observed in patients with LVH and systolic dysfunction, with or without FP. CONCLUSION: In FAP, NT-proBNP was associated with cardiac impairment suggesting that NT-proBNP could be used in carriers or in FAP patients with only neurologic symptoms for identifying the appropriate time to start cardiac echocardiographic assessment and follow-up. cTnT identified patients with severe cardiac disease.
Fichier principal
Vignette du fichier
Damy_et_al_Table_1_and_2.pdf (50.56 Ko) Télécharger le fichier
Damy_et_al_Article_Final_v2.pdf (146.59 Ko) Télécharger le fichier
Diapositive1.TIF (100.44 Ko) Télécharger le fichier
Diapositive2.TIF (107.16 Ko) Télécharger le fichier
Diapositive3.TIF (84.44 Ko) Télécharger le fichier
Diapositive4.TIF (75.44 Ko) Télécharger le fichier
Diapositive5.TIF (64.31 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Origine : Fichiers produits par l'(les) auteur(s)
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Format : Autre

Dates et versions

inserm-00856266 , version 1 (12-08-2014)

Identifiants

Citer

Thibaud Damy, Jean-François Deux, Stéphane Moutereau, Soulef Guendouz, Dania Mohty, et al.. Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis.: Cardiac biomarkers in FAP. Amyloid: The Journal of Protein Folding Disorders, 2013, 20 (4), pp.212-20. ⟨10.3109/13506129.2013.825240⟩. ⟨inserm-00856266⟩
327 Consultations
683 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More